GlassScriptPhysician profile
David Lee Tung
NPI 1972799799
$1,058.34
in general payments reported to CMS, 2019-2025
13 companies · $94.86 in 2025
The $94.86 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $238 · 2021: $256 · 2022: $151 · 2023: $273 · 2024: $45.02 · 2025: $94.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $412.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $371.77 | 2020-2022 | |
| Abbott Laboratories | $223.25 | 2020-2025 | Proclaim, Eterna |
| Abbvie INC. | $97.40 | 2023-2025 | Botox |
| Amneal Pharmaceuticals LLC | $81.26 | 2023 | Lyvispah |
| Si-Bone, INC. | $69.69 | 2023 | |
| Nevro Corp. | $67.22 | 2021-2022 | |
| Valinor Pharma, LLC | $24.10 | 2025 | Movantik |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.58 | 2025 | Relistor |
| Nalu Medical, INC. | $22.51 | 2024 | Nalu Neurostimulation System |
| Saluda Medical Americas, INC. | $22.51 | 2024 | Evoke |
| Vertos Medical, INC. | $19.68 | 2022 | |
| Spinal Simplicity, LLC | $18.84 | 2023 | Ha Minuteman G3-R |
| Horizon Therapeutics Plc | $17.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Tung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.